Randomised Controlled TrialiVNSn = 532

Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF Trial

Konstam MA, Udelson JE, Mann DL, DiCarlo L, Butler J, Ardell J, De Ferrari GM, Klein HU, Filippatos G, Metra M, et al.

JACC · 2026

Key finding

In the ANTHEM-HF-2 RCT (532 patients; enrollment terminated early), VNS did NOT meet its primary efficacy endpoint in heart failure with reduced ejection fraction, though device safety was high.

Auto-extracted · verification pendingHow we verify

Condition
Heart Failure
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
532
View on DOI

Share this study

Download the citation card as a PNG, or copy a link to this page.

Cite this study

Konstam, M. A., Udelson, J. E., Mann, D. L., DiCarlo, L., Butler, J., Ardell, J., De Ferrari, G. M., Klein, H. U., Filippatos, G., Metra, M., Anand, I., Close, N., Saville, B. R., Detry, M. A., Paulon, G., Khandwala, F., Bosse, A., KenKnight, B., Mindrebo, S., … Teerlink, J. R. (2026). Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF Trial. JACC, 87(25), 3490-3502. https://doi.org/10.1016/j.jacc.2026.03.040

Related studies in Heart Failure

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.